MISSISSAUGA, Ontario (AP) _ Trillium Therapeutics Inc. (TRIL) on Friday reported a loss of $70.1 million in its first quarter.
On a per-share basis, the Mississauga, Ontario-based company said it had a loss of $1.07. Losses, adjusted for non-recurring costs, were 23 cents per share.
Trillium shares have climbed fivefold since the beginning of the year. In the final minutes of trading on Friday, shares hit $5.83, rising ninefold in the last 12 months.